Otsuka Holdings Co., Ltd. (OTSKF)
58.42
0.00 (0.00%)
USD |
OTCM |
Dec 10, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 30.85B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 2.40% |
| Valuation | |
| PE Ratio | 10.36 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 1.918 |
| Price to Book Value | 1.594 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 0.4458 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.0764 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 37.01% |
Profile
| Otsuka Holdings Co., Ltd. engages in the management of its group companies which are in the pharmaceuticals business. It operates through the following segments: Pharmaceuticals, Nutraceuticals, Consumer Products, and Others. The Pharmaceuticals segment manufactures therapeutic drugs and infusions focusing on the central nervous system, oncology, and infectious diseases. The Nutraceuticals segment develops and markets nutrition products such as nutritional food, quasi-drugs, health drinks, and dietary supplements for homes, medical facilities, and nursing care units. The Consumer Products segment sells mineral water, food, and beverages. The Others segment distributes functional and fine chemicals, optical inspection devices, and clinical diagnosis equipment. The company was founded on July 8, 2008 and is headquartered in Tokyo, Japan. |
| URL | https://www.otsuka.com/jp/ |
| Investor Relations URL | http://www.otsuka.com/en/ir/ |
| HQ State/Province | Tokyo |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Feb. 13, 2026 |
| Last Earnings Release | Oct. 31, 2025 |
| Next Ex-Dividend Date | Dec. 31, 2025 |
| Last Ex-Dividend Date | Jun. 30, 2025 |
Ratings
Profile
| Otsuka Holdings Co., Ltd. engages in the management of its group companies which are in the pharmaceuticals business. It operates through the following segments: Pharmaceuticals, Nutraceuticals, Consumer Products, and Others. The Pharmaceuticals segment manufactures therapeutic drugs and infusions focusing on the central nervous system, oncology, and infectious diseases. The Nutraceuticals segment develops and markets nutrition products such as nutritional food, quasi-drugs, health drinks, and dietary supplements for homes, medical facilities, and nursing care units. The Consumer Products segment sells mineral water, food, and beverages. The Others segment distributes functional and fine chemicals, optical inspection devices, and clinical diagnosis equipment. The company was founded on July 8, 2008 and is headquartered in Tokyo, Japan. |
| URL | https://www.otsuka.com/jp/ |
| Investor Relations URL | http://www.otsuka.com/en/ir/ |
| HQ State/Province | Tokyo |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Feb. 13, 2026 |
| Last Earnings Release | Oct. 31, 2025 |
| Next Ex-Dividend Date | Dec. 31, 2025 |
| Last Ex-Dividend Date | Jun. 30, 2025 |